India to Denmark: Albendazole Export Trade Route
India has recorded 47 verified shipments of Albendazole exported to Denmark, representing a combined trade value of $5.3M USD. This corridor is served by 4 active Indian exporters, with an average shipment value of $112.0K USD. The leading Indian exporter is MEDOPHARM, which accounts for 41% of total export value with 18 shipments worth $2.2M USD. On the buying side, UNICEF SUPPLY DIVISION is the largest importer in Denmark with $1.4M USD in purchases. The top 3 suppliers — MEDOPHARM, MEPRO PHARMACEUTICALS PRIVATE LIMITED, MEDOPHARM — together control 87% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Denmark Albendazole corridor is one of India's established pharmaceutical export routes, with 47 shipments documented worth a combined $5.3M USD. The route is dominated by MEDOPHARM, which alone accounts for roughly 41% of all export value, reflecting the consolidated nature of India's albendazole manufacturing sector.
Across 4 active suppliers, the average shipment value stands at $112.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 74% of all shipments, consistent with albendazole's non-urgent bulk-order profile.
Shipment activity peaks during UNAVAILABLE, with an average transit time of 29 days port-to-port. The route has recorded an annual growth rate of 27.8%, placing it at rank #8 among India's top albendazole export destinations globally.
On the import side, key buyers of Indian albendazole in Denmark include UNICEF SUPPLY DIVISION, UNICEF SUPPLY DIVISION,, M/S. UNICEF SUPPLY DIVISION and 5 others. UNICEF SUPPLY DIVISION is the single largest importer with 11 shipments valued at $1.4M USD.
